Benitec Biopharma Inc.

Historical 13F Holders

Symbol
BNTC
CUSIP
08205P209
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 08205P209 since 12/18/2024, largest first.

Filer % of Class Filed
Suvretta Capital Management, LLC 13D/A
44.1% 11/10/2025
Event 11/7/2025
Franklin Resources, Inc. 13G/A
10.6% 1/29/2026
Event 12/31/2025
Janus Henderson Group PLC 13G/A
10.0% 12/8/2025
Event 11/28/2025
RA Capital Management, L.P. 13G
5.5% 12/3/2025
Event 11/7/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
HBM Healthcare Investments (Cayman) Ltd. 13G/A 4.5% 2/13/2025
Event 12/31/2024
Nantahala Capital Management, LLC 13G/A
4.4% 5/15/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 8.29 k $82.9 k
2026 Q2 90 34.7 M $464 M
2026 Q1 89 32.5 M $346 M
2025 Q4 73 31.7 M $427 M
2025 Q3 58 23.2 M $325 M
2025 Q2 60 22.7 M $265 M
2025 Q1 39 21.9 M $290 M
2024 Q4 31 19.0 M $240 M
2024 Q3 26 13.7 M $127 M
2024 Q2 20 5.74 M $40.0 M
2024 Q1 16 1.29 M $6.70 M
2023 Q4 15 1.20 M $3.90 M
2023 Q3 12 1.27 M $3.84 M